{'fraction_non_alphanumeric': 0.03515625, 'fraction_numerical': 0.01171875, 'mean_word_length': 5.493670886075949, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Regulation of ICAM‐3 and other adhesion molecule expressions on eosinophils in vitro. Effects of dexamethasone

Background: ICAM‐3 has been recently identified as the third leukocyte‐function associated‐1 (LFA‐1) ligand. ICAM‐3 is expressed in eosinophils, but its regulation has not been studied. The objective of this study was to investigate the differential expression of ICAM‐3 and other adhesion molecules (AM) on the surface of eosinophils. We also evaluated the effects of dexamethasone on AM expression.